Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities (Abstract)

Am J Ment Retard
July 2001
https://pubmed.ncbi.nlm.nih.gov/11414874/

Erratum: in Table 1 a column heading was inadvertently omitted. See Am J Ment Retard 2001 Sep;106(5):469

Naltrexone plasma levels, clinical response and effect on weight in autistic children

Psychopharmacol Bull
1994
https://pubmed.ncbi.nlm.nih.gov/7831456/

Naltrexone in autistic children: a double-blind and placebo-controlled study

Psychopharmacol Bull
September 1990
http://www.ncbi.nlm.nih.gov/pubmed/?term=2196621

Effect of naltrexone upon self-injurious behavior, learning and activity: a case study

Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders

J Autism Dev Disord
October 2000
https://www.ncbi.nlm.nih.gov/pubmed/?term=11098883

Naltrexone in autistic children: behavioral symptoms and attentional learning

J Am Acad Child Adolesc Psychiatry
November 1993
https://www.ncbi.nlm.nih.gov/pubmed/?term=8282676

Objective: To assess critically the short-term efficac y and safety of naltrexone in autistic children and its effects on discrimination learning in the laboratory.

Beta-endorphin levels in peripheral blood mononuclear cells and long-term naltrexone treatment in autistic children

Eur Neuropsychopharmacol
June 1999
https://www.ncbi.nlm.nih.gov/pubmed/?term=10422898

Naltrexone in autistic children: an acute open dose range tolerance trial

J Am Acad Child Adolesc Psychiatry
March 1989
http://www.ncbi.nlm.nih.gov/pubmed/?term=2925573

Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone

Encephale
Mar-Apr 1993
http://www.ncbi.nlm.nih.gov/pubmed/8275903

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children

Psychopharmacol Bull
1993
https://pubmed.ncbi.nlm.nih.gov/8290669/